Regulatory News
Tuesday, December 27, 2016
REFILE-FDA puts clinical hold on Seattle Genetics' cancer drug after 4 deaths
Dec 27 (Reuters) - Seattle Genetics Inc said on
Tuesday that four people had died in trials testing its
experimental cancer drug, prompting the U.S. Food and Drug
Administration to impose a clinical...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment